
Dis-Chem is the flagship retail brand of Dis-Chem Pharmacies Limited, a JSE-listed South African company (DCP) founded by Ivan and Lynette Saltzman in 1978. The chain operates about 285 large-format pharmacy stores plus clinics and an online shop, and the group reported R39.2 billion in FY2025 revenue.
Parent Company
Founded
1978
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Dis-Chem | Dis-Chem Pharmacies Limited | Brand division |
Ivan and Lynette Saltzman opened the first Dis-Chem in 1978 in Mondeor, south Johannesburg, with an unusual idea for the era: a discount pharmacy. Regulatory limits on corporate pharmacy ownership kept growth slow until 2003, when South Africa allowed corporate-owned pharmacies and the chain began scaling.
Through the 2000s Dis-Chem perfected its large-format model: destination stores combining a dispensary with beauty, health, baby and household categories at discounted prices. Its CJ Distribution wholesale arm supplied its own stores plus independent pharmacies, creating an integrated retail-wholesale engine.
The November 2016 JSE listing funded accelerated expansion, baby store acquisitions and healthcare services. Ivan Saltzman led the company for 45 years before Rui Morais succeeded him as CEO in 2023. FY2025 produced R39.2 billion revenue across 285 pharmacy stores, 45 baby stores and a wholesale operation whose external sales grew 22.1 percent.
Who owns Dis-Chem?
It is a JSE-listed public company. Founders Ivan and Lynette Saltzman and family interests remain the largest shareholder block, with institutional investors holding most of the float.
Is Dis-Chem publicly traded?
Yes. Dis-Chem Pharmacies listed on the Johannesburg Stock Exchange in November 2016 under the ticker DCP.
When was Dis-Chem founded?
Ivan and Lynette Saltzman founded Dis-Chem in 1978, opening the first store in Mondeor, Johannesburg.
How many Dis-Chem stores are there?
As of FY2025 the group operated 285 retail pharmacy stores and 45 baby stores, with approximately 39 additional stores planned during FY2026.
What is the difference between Dis-Chem and Clicks?
Both are South African pharmacy chains. Clicks has roughly three times as many stores; Dis-Chem operates larger-format stores and runs a bigger wholesale business supplying independent pharmacies and its TLC franchise network.
Who is the CEO of Dis-Chem?
Rui Morais, formerly the group's CFO, became CEO in October 2023, succeeding founder Ivan Saltzman.
Dis-Chem operates one of South Africa's largest private primary clinic networks, positioning affordable healthcare access as its core social contribution. Its integrated report covers pharmaceutical waste disposal, responsible house-brand sourcing and B-BBEE transformation metrics. It is not a certified B Corp. Product recalls flow through manufacturer-led pharmaceutical recall protocols executed at pharmacy level.
The brand's most publicized episode was a 2022 leaked internal memo imposing a moratorium on white management appointments, which sparked national debate about its transformation approach and drew an apology. Periodic complaints concern dispensary pricing and wait times at popular stores. It has no major unresolved regulatory sanctions on record.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Cvs Health | USA | 1963 | Mass market | United states | All Genders | |
| Cvs Health | United States | 1938 | Mass market | United states | All Genders | |
| Cvs Health | United States | 1940 | Mass market | Regional | All-ages | |
| Adcock Ingram | South Africa | 1891 | Mass market | Regional | All Genders | |
| Amazon | USA | 2020 | Mass market | United states | All Genders | |
| Walmart | South Africa | 1980 | Mass market | Regional | All Genders |
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American pharmacy retail chain and one of the largest pharmacy networks in the United States, owned by CVS Health.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American pharmacy retail chain operating in Hawaii, owned by CVS Health. Approximately 70 stores serving Hawaiian communities.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
Retail pharmacy chain serving Hispanic and Latino communities in South Florida. Owned by CVS Health since 2014. 33 stores across Miami-Dade, Broward, Tampa, and Orlando.
Healthcare PharmaceuticalsOwned by Adcock Ingram Holdings Limited
South African pharmaceutical brand behind Panado and Myprodol, now privately held by Bidvest and NATCO Pharma.
Healthcare PharmaceuticalsOwned by Amazon.com Inc.
Amazon's online pharmacy service offering prescription medications and home delivery, operating as a division of Amazon.com Inc.
Retail EcommerceOwned by Walmart Inc.
South African retail group behind Game, Makro, and Builders, wholly owned by Walmart since 2022 and headquartered in Sandton.
Market Positioning: Dis-Chem competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Dis-Chem Pharmacies Limited, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Adcock Ingram Holdings Limited
South African pharmaceutical brand behind Panado and Myprodol, now privately held by Bidvest and NATCO Pharma.
Adcock Ingram is privately owned, unlike Dis-Chem which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.
Walgreens is privately owned, unlike Dis-Chem which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
Band-Aid is privately owned, unlike Dis-Chem which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
Boots is privately owned, unlike Dis-Chem which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
Duane Reade is privately owned, unlike Dis-Chem which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Nexon Pharma Sp. z o.o.
Polish dietary supplement and medical device brand owned by Nexon Pharma Sp. z o.o. of Warsaw, sold through pharmacies.
Nexon Pharma is privately owned, unlike Dis-Chem which is under a publicly traded parent company.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.